1 documents found
Information × Registration Number 0211U007152, 0110U007780 , R & D reports Title A randomized, double-blind, placebo-controlled study of phase II safety and efficacy of HPN-100 for the maintenance of remission in patients with liver cirrhosis and episodic hepatic encephalopathy (HALT-HE) popup.stage_title Head Popov Sergi Borisovich, Registration Date 30-03-2011 Organization Nation University of Pharmacy popup.description2 Placebo-kontrolovannya Phase II study of safety and efficacy of HPN-100 for the maintenance of remission in patients with liver cirrhosis and episodic hepatic encephalopathy (HALT-HE) Product Description popup.authors Єлезева М.В. Андрєєва О.О. Безугла Н.П. Варич В.В. Гринцов Є.Ф. Зупанеці І.А. Кізь М.І. Мірошніченко В.В. Місюрьова С.В. Маслій Г.В. Рускін О.С. Сальцева М.В. popup.nrat_date 2020-04-02 Close
R & D report
A randomized, double-blind, placebo-controlled study of phase II safety and efficacy of HPN-100 for the maintenance of remission in patients with liver cirrhosis and episodic hepatic encephalopathy (HALT-HE)
Head: Popov Sergi Borisovich. A randomized, double-blind, placebo-controlled study of phase II safety and efficacy of HPN-100 for the maintenance of remission in patients with liver cirrhosis and episodic hepatic encephalopathy (HALT-HE). (popup.stage: ). Nation University of Pharmacy. № 0211U007152
1 documents found

Updated: 2026-03-21


Роздрукувати цю сторінку